Literature DB >> 12791439

Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia.

R R Leker1, M Y Neufeld.   

Abstract

Many similarities exist between cerebral ischemia and epilepsy regarding brain-damaging and auto-protective mechanisms that are activated following the injurious insult. Therefore, drugs that are effective in minimizing seizure-induced brain damage may also be useful in minimizing ischemic injury. Use of such drugs in stroke victims may have important clinical and financial advantages. Therefore, the authors conducted a Medline search of studies involving the use of anti-epileptic drugs (AEDs) as possible neuroprotectants and summarize the data. Most AEDs have been tested in animal models of focal or global ischemia and some were already tested in humans, for a possible neuroprotective effect. The existing data is rather scant and insufficient but it appears that only drugs that have multiple mechanisms of action seem to have some potential in conferring a degree of neuroprotection that could be clinically applicable to stroke patients. In conclusion, some of the newer AEDs show promise as possible neuroprotectants in the setup of acute ischemic stroke but more studies are needed before clinical trials in humans could be undertaken.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791439     DOI: 10.1016/s0165-0173(03)00170-x

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  8 in total

Review 1.  Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.

Authors:  D Caccamo; L R Pisani; P Mazzocchetti; R Ientile; P Calabresi; F Pisani; C Costa
Journal:  Neurochem Res       Date:  2015-12-31       Impact factor: 3.996

2.  Different effects of high- and low-dose phenobarbital on post-stroke seizure suppression and recovery in immature CD1 mice.

Authors:  Geoffrey J Markowitz; Shilpa D Kadam; Dani R Smith; Michael V Johnston; Anne M Comi
Journal:  Epilepsy Res       Date:  2011-04-09       Impact factor: 3.045

3.  Treatment of seizures in the neurologic intensive care unit.

Authors:  Panayiotis N Varelas; Marek Mirski
Journal:  Curr Treat Options Neurol       Date:  2007-03       Impact factor: 3.598

4.  Levetiracetam Prevents Perforin Mediated Neuronal Injury Induced by Acute Cerebral Ischemia Reperfusion.

Authors:  Yue Zhang; Ying Li; Lian Zuo; Huan Bao; Xiahong Xu; Junjie Hao; Xin Wang; Gang Li
Journal:  Mol Neurobiol       Date:  2015-10-10       Impact factor: 5.590

Review 5.  Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors.

Authors:  Tapan Behl; Dapinder Kaur; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Gokhan Zengin; Felicia Liana Andronie-Cioara; Mirela Marioara Toma; Simona Bungau; Adrian Gheorghe Bumbu
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

Review 6.  Use of prophylactic anticonvulsants in neurologic critical care: a critical appraisal.

Authors:  Kenneth C Liu; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.532

7.  The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion.

Authors:  Ornella Cuomo; Vincenzo Rispoli; Antonio Leo; Giovanni Bosco Politi; Antonio Vinciguerra; Gianfranco di Renzo; Mauro Cataldi
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 8.  Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.

Authors:  Dmitriy Matveychuk; Erin M MacKenzie; David Kumpula; Mee-Sook Song; Andrew Holt; Satyabrata Kar; Kathryn G Todd; Paul L Wood; Glen B Baker
Journal:  Cell Mol Neurobiol       Date:  2021-04-10       Impact factor: 5.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.